Two-dose exposure of intra-arterial chemotherapy for group D retinoblastoma
Anne Hutchinson1, Swathi Kaliki, Carol L Shields
1Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Journal of Pediatric Ophthalmology and Strabismus
|March 27, 2012
Abstract:
The authors present a case of group D unilateral sporadic retinoblastoma treated with only two intra-arterial chemotherapy cycles using melphalan, which resulted in tumor regression, resolution of subretinal fluid, and, most importantly, salvage of the life, and the eye.
